This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Prostate Health Market

Prostate Health Market Analysis by Disease Indication (Prostate Cancer, Benign Prostate Hyperplasia, and Prostatitis), & Region - Forecast to 2022-2032

Market Insights on Prostate Health covering sales outlook, demand forecast & up-to-date key trends

Prostate Health Market Outlook

[309 Pages Report]  The global Prostate Health Market is anticipated to reach US$ 50 Bn in 2026, from US$ 32 Bn in 2021, with a CAGR of 9% during 2022-2032.

"Factors such as the presence of a large target patient population, rising healthcare expenditures, increased physician awareness, and significant rise in the senior population are projected to drive higher demand for prostate health solutions."

While BPH (Benign Prostate Hyperplasia) rarely causes symptoms before the age of 40, the disease's risk increases as one get older. Nearly half of males between the ages of 51 and 60 are affected, while up to 90% of men over 80 are affected. Patients with BPH have received treatment in the form of medicines and surgery.

Attributes

Details

Prostate Health Market CAGR (2022 – 2032)

9%

Prostate Health Market (2032)

US$ 83 Bn

Prostate Health Market Attraction

Awareness about the symptoms of BPH to drive growth of the prostate health market.

How Adverse is the Effect of COVID-19 on Prostate Health Market?

“Efficiently treating patients with best prostate medicine during the pandemic crisis became a serious issue for doctors. Due to the changing medical and surgical importance of prostate cancer, services were put on hold affecting the prostate health market.”

According to major regulatory bodies throughout the world, patients with prostate cancer are more at risk of contracting the coronavirus, which can cause disease and death if they become infected (such as the CDC, WHO, MHRA, TGA, and EMA). Prostate care, diagnostic tests, and surgical treatments in hospitals and prostate cancer centres were severely limited, affecting the global prostate health market

Prostate cancer patients can use telemedicine prostate health supplements, make lifestyle modifications, identify early signs of prostate problems, and keep social distance once everything is in order and the virus has been contained.

Patients with prostate cancer were monitored remotely while the COVID 19 pandemic got under control. Gender, age, and propensity factors have all increased the occurrence and mortality of COVID 19 infection in prostate cancer patients, which is likely to boost the demand for prostate healthcare.

Customize this Report

Let us know your requirement to get
100% FREE customization

What are the Primary Drivers of the Prostate Health Market?

"The market is being driven ahead by demand for hormone treatment medications, developing therapeutics for prostate cancer, and the increased incidence of prostatitis."

The rising prevalence of benign prostatic hyperplasia, increasing obesity, investments, funds, and grants for research in BPH treatment, rising prevalence of prostate cancer, increasing demand for hormone therapy drugs, emerging therapies for prostate cancer, and the rising incidence of prostatitis are all driving the market forward.

Prostate cancer becomes more common as men become older, and it is the most common type of cancer in males. Prostate cancer caused roughly 248,530 new cases and 34,130 deaths in the United States in 2020, according to the American Cancer Society's predictions for 2021. Prostate cancer cases are on the rise, increasing market demand for prostate health supplements.

What are the Factors Hampering the Growth of the Prostate Health Market?

While both medicines and surgery can treat BPH, both have severe adverse effects. Alpha-blockers, 5-ARIs (5-alpha reductase inhibitors), and other medication groups are routinely used to treat BPH.

Dizziness, orthostatic hypotension, retrograde ejaculation, and rhinitis are all common side effects of alpha-blockers. Dizziness and orthostatic hypotension are more common in the elderly, leading to severe complications, such as falls and accidents.

These medications also suppress the manufacture of certain neuroactive hormones, but they may cause depression via modulating the neuroendocrine stress response. Gynecomastia, impotence, decreased libido and ejaculate volume are among the adverse effects of 5-ARIs.

What are the Opportunities for the Prostate Health Market?

"Emerging economies in diverse countries with significant healthcare spending and physician awareness open the market to a variety of opportunities."

Emerging economies (such as China, India, Brazil, and Mexico) are likely to provide considerable growth prospects for market competitors in the next few years. Factors such as a significant target patient population, rising healthcare expenditures, increasing physician awareness, and significant growth in the senior population are likely to drive up demand for prostate health solutions in these nations.

A substantial and quickly rising patient population for benign prostatic hyperplasia can be found throughout the Asia Pacific. Furthermore, across the area, particularly in Japan, China, South Korea, and Hong Kong, the number of geriatric adults at a higher risk for these target indications in the total population is predicted to rise substantially.

Given these circumstances, prominent and rising prostate health product manufacturers are increasingly focusing on extending their companies across emerging Asia Pacific countries.

What are the Challenges faced by the Prostate Health Market Players?

BPH is frequently misdiagnosed as an untreatable symptom of ageing rather than a disorder managed by visiting urologist.

Due to a lack of awareness about the signs and symptoms of BPH, many men may go misdiagnosed, thereby worsening the damage to the prostate.

What are the Key Trends in the Prostate Health Market?

The growing incidence of benign prostatic hyperplasia, obesity, investment opportunities, resources, and funding for research in BPH treatment, rising prevalence of prostate cancer, growing preference for hormone therapy drugs, evolving treatments for prostate cancer, and the high rate of prostatitis are all driving the prostate health market share forward.

Prostate cancer, benign prostate hyperplasia, and prostatitis are the three disease indications that make up the prostate health industry. Prostate cancer will hold the most significant share of the prostate health market in 2020. Hormone therapy is generally thought to be an impactful first-line treatment for prostate cancer. 

Following hormonal therapy, cancer vaccines, radiopharmaceutical agents, secondary hormone therapies, prostate health capsules or chemotherapies are used as alternative therapies. Following the discovery that cancerous cells build immunity to these medicines after a few months, immunotherapies are predicted to be widely embraced for the treatment of prostate cancer in the coming years.

Due to a lack of understanding about the clinical manifestations of prostate health meaning and symptoms, many men may go misdiagnosed, thereby worsening the damages to the prostate.

North America has been a pioneer in developing prostate health supplements in the medical sector. The rising target demographic, the high proportion of BPH, prostate cancer, and prostatitis, and the significant influence of medical device makers contribute to the higher growth in the United States.

Supportive regulations, high disposable earnings, solid healthcare infrastructure, funding for research, and product releases have all contributed to the prostate health market growth.

In the subsequent years, developing markets (such as China, India, Brazil, and Mexico) is likely to provide considerable growth prospects for market competitors. Factors like the relatively large target percentage of patients, rising medical spending, increasing physician understanding, and massive increase in the senior population are likely to drive up demand for prostate health solutions in these nations.

Comparative View of Adjacent Prostate Health Market

Prostate Health Market:

Attributes

Prostate Health Market

CAGR (2022 - 2032)

9%

Market Value (2026)

US$ 50 Bn

Growth Factor

Rising prevalence of prostate cancer as well as BPH to drive adoption.

Opportunity

Increasing awareness among physicians to augment opportunities in the prostate health market.

Key Trends

Growing research funding as well as favorable reimbursement policies to remain a key trend.

Prostate Cancer Therapeutics Market:

Attributes

Prostate Cancer Therapeutics Market

CAGR (2022 - 2032)

5%

Market Value (2026)

US$ 9.9 Bn

Growth Factor

Low cost of therapeutics over radiotherapy to provide opportunities in developing countries.

Opportunity

Launching of drugs with short market times to provide opportunities.

Key Trends

Multiple products and parallel clinical trials of therapeutics to remain a key differentiator.

Radiotherapy Market:

Attributes

Radiotherapy Market

CAGR (2022 - 2032)

4%

Market Value (2026)

US$ 7 Bn

Growth Factor

Awareness about radiotherapy procedure to cure cancer is governing the demand.

Opportunity

Market players can focus on reducing the expensiveness of radiotherapy to penetrate into developing economies.

Key Trends

Advancements and innovation in radiotherapy to boost growth.

The prostate health market had a decline in sales, which is expected to continue until late December 2020. Unfavourable changes are hampering this industry's expansion in legislation and norms. 

According to major regulatory bodies throughout the world, cancer patients are more likely to get COVID-19 infection than healthy persons (such as the CDC, WHO, MHRA, TGA, and EMA). As a result, screening, diagnostic tests, and surgical operations are severely limited or delayed in hospitals and cancer treatment facilities.

The market is primarily driven by the rising prevalence of prostate cancer, increased public knowledge about prostate cancer therapy, and the availability of novel medications and prostate cancer therapies.

The growing targeted audience, the high prevalence of BPH, prostate cancer, and prostatitis, and the strong presence of medical device makers are all critical contributors to market expansion in the US (a pivotal contributor to the North American prostate health market).

Favourable reimbursement regulations, high disposable incomes, a solid healthcare infrastructure, research funding, and product releases have all expanded the market.

Cancerous cells acquire resistance to these medicines, and immunotherapies are predicted to be widely embraced to treat prostate cancer in the near future.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Which Disease Indication Segment Holds the Largest Share in the Prostate Health Market?

The prostate cancer segment is expected to have a significant market share in the global prostate health market by 2032.

The market is primarily driven by the rising prevalence of prostate cancer, increased public knowledge about prostate cancer therapy, and the availability of novel medications and prostate cancer treatments. The increasing rise in the number of instances of prostate cancer presents enormous prospects for market participants. 

The key industry players concentrate their R&D efforts to deliver innovative and genuine prostate therapies to the prostate health market. Innovative technologies in screening and diagnostic testing for prostate diseases are projected to drive market expansion. The use of multiparametric MRI (MP-MRI) can significantly improve tumour detection.

What is the Regional Outlook for the Prostate Health Market?

North America dominated the prostate health market in 2020, and the region is predicted to rise at a 7.6% CAGR by 2032. North America has been a leader in developing prostate health therapies in the medical field. 

The rising target population, the high incidence of BPH (prostate problems in older men), prostate cancer, and prostatitis, and the strong presence of medical device manufacturers are all contributing to the market expansion in the United States (a significant contributor to the North American prostate health market). 

Favourable reimbursement regulations, high disposable incomes, a competent healthcare infrastructure, research funding for prostate vitamins, and product releases like prostate support have contributed to the rapid growth of the prostate health market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Who are the Prominent Players in the Prostate Health Market?

The introduction of the new and best prostate supplement will substantially impact the prostate health market. A greater understanding of disease pathogenesis will aid in the development of new prostate cancer therapeutics.

The development of therapies for prostate cancer involves several significant players like Eli Lilly and Company (US), Pfizer Inc. (US), Merck & Co., Inc. (US), GlaxoSmithKline plc. (UK), Abbott (US), Astellas Pharma Inc. (Japan), Johnson & Johnson Services, INC., AbbVie, SANOFI.

These key players and academics in the prostate health market assess challenges and look for chances to improve prostate cancer research and development. Novel techniques to treat/improve the disease status focus on prostate cancer therapies in the prostate health market.

Recent Developments in the Prostate Health Market:

  • Butterfly Medical, an Israeli medical device manufacturer, raised USD 7 million in Series B financing in October 2020 to develop an anatomically designed nitinol implant positioned in the prostatic urethra to alleviate BPH symptoms.
  • Zenflow, a medical device company based in California, announced a USD 31.4 million Series A funding round in February 2018 to continue its minimally invasive method to treat BPH. Its solution is a device that props open the urethra, effectively curing BPH symptoms without surgery or medicine.
  • ProArc Medical, based in Israel, was awarded a USD 2.2 million grant from the Horizon 2020 programme as part of the European Innovation Council pilot in July 2019. The two-year award will fund the research and development of ProArc's ClearRing BPH implant, as well as its commercialization.

Key Segments

By Disease Indication:

  • Prostate Cancer
  • Benign Prostate Hyperplasia
  • Prostatitis

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Frequently Asked Questions

The global prostate health market is expected to register a CAGR of 9% from 2022 to 2032.

The size of the prostate health market is anticipated to be valued at US$ 83 Bn by 2032.

The size of the prostate health market was worth US$ 32 Bn in 2021.

The North American region dominates the global prostate health market.

Prostate cancer caused roughly 248,530 new cases in the United States in 2020 and is anticipated to offer huge opportunities in the future.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook 

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Fact.MR Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy 

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment 

    3.1. Risk Assessment 

        3.1.1. COVID-19 Crisis and Impact on Prostate Health Demand

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis 

        3.1.3. Impact on Market Value (US$ Mn)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points 

    4.1. Global Prostate Health Market (US$ Mn)

    4.2. Prostate Health Market Opportunity Assessment (US$ Mn)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast 

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario 

    4.4. Investment Feasibility Analysis 

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact 

        4.5.1. Top Companies Historical Growth

        4.5.2. Global Prostate Health Market Growth

        4.5.3. Prostate Health Adoption Rate, by Country

    4.6. Market Dynamics 

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Prostate Health Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors 

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking 

6. Global Prostate Health Market Demand Analysis 2015-2021 and Forecast, 2022-2032

    6.1. Historical Market Analysis, 2015-2021

    6.2. Current and Future Market Projections, 2022-2032

    6.3. Y-o-Y Growth Trend Analysis

7. Global Prostate Health Market Value Analysis 2015-2021 and Forecast, 2022-2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032, By Disease Indication

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Disease Indication, 2015-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Indication, 2022-2032

        8.3.1. Prostate Cancer

            8.3.1.1. AR Directed Therapies

            8.3.1.2. Hormone ADT

            8.3.1.3. Cytotoxic Agents

            8.3.1.4. PARP Inhibitors

            8.3.1.5. Others

        8.3.2. Benign Prostate Hyperplasia

            8.3.2.1. Alpha Blockers

                8.3.2.1.1. Alfuzosin

                8.3.2.1.2. Doxazosin

                8.3.2.1.3. Tamsulosin

                8.3.2.1.4. Silodosin

                8.3.2.1.5. Other Alpha Blockers

            8.3.2.2. 5 Alpha Reductase

                8.3.2.2.1. Finasteride

                8.3.2.2.2. Dutasteride

            8.3.2.3. Others

        8.3.3. Prostatitis

            8.3.3.1. Prescription

            8.3.3.2. Over the Counter

    8.4. Market Attractiveness Analysis By Disease Indication

9. Global Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032, By Region

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021

    9.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. Asia Pacific 

        9.3.5. Middle East and Africa (MEA)

    9.4. Market Attractiveness Analysis By Region

10. North America Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

    10.1. Introduction

    10.2. Pricing Analysis

    10.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    10.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        10.4.1. By Country

            10.4.1.1. U.S.

            10.4.1.2. Canada

        10.4.2. By Disease Indication

    10.5. Market Attractiveness Analysis

        10.5.1. By Country

        10.5.2. By Disease Indication

11. Latin America Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

    11.1. Introduction

    11.2. Pricing Analysis

    11.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    11.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        11.4.1. By Country

            11.4.1.1. Brazil

            11.4.1.2. Mexico

            11.4.1.3. Rest of Latin America

        11.4.2. By Disease Indication

    11.5. Market Attractiveness Analysis

        11.5.1. By Country

        11.5.2. By Disease Indication

12. Europe Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    12.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        12.4.1. By Country

            12.4.1.1. Germany

            12.4.1.2. France

            12.4.1.3. U.K.

            12.4.1.4. Italy

            12.4.1.5. Benelux

            12.4.1.6. Nordic Countries

            12.4.1.7. Rest of Europe

        12.4.2. By Disease Indication

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Disease Indication

13. Asia Pacific Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    13.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        13.4.1. By Country

            13.4.1.1. China

            13.4.1.2. Japan

            13.4.1.3. South Korea

            13.4.1.4. Rest of Asia Pacific

        13.4.2. By Disease Indication

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Disease Indication

14. Middle East and Africa Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Value (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021

    14.4. Market Value (US$ Mn) & Forecast By Market Taxonomy, 2022-2032

        14.4.1. By Country

            14.4.1.1. GCC Countries

            14.4.1.2. South Africa

            14.4.1.3. Turkey

            14.4.1.4. Rest of Middle East and Africa

        14.4.2. By Disease Indication

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Disease Indication

15. Key Countries Prostate Health Market Analysis 2015-2021 and Forecast 2022-2032

    15.1. Introduction

        15.1.1. Market Value Proportion Analysis, By Key Countries

        15.1.2. Global Vs. Country Growth Comparison

    15.2. US Prostate Health Market Analysis

        15.2.1. Value Proportion Analysis by Market Taxonomy

        15.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.2.2.1. By Disease Indication

    15.3. Canada Prostate Health Market Analysis

        15.3.1. Value Proportion Analysis by Market Taxonomy

        15.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.3.2.1. By Disease Indication

    15.4. Mexico Prostate Health Market Analysis

        15.4.1. Value Proportion Analysis by Market Taxonomy

        15.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.4.2.1. By Disease Indication

    15.5. Brazil Prostate Health Market Analysis

        15.5.1. Value Proportion Analysis by Market Taxonomy

        15.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.5.2.1. By Disease Indication

    15.6. Germany Prostate Health Market Analysis

        15.6.1. Value Proportion Analysis by Market Taxonomy

        15.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.6.2.1. By Disease Indication

    15.7. France Prostate Health Market Analysis

        15.7.1. Value Proportion Analysis by Market Taxonomy

        15.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.7.2.1. By Disease Indication

    15.8. Italy Prostate Health Market Analysis

        15.8.1. Value Proportion Analysis by Market Taxonomy

        15.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.8.2.1. By Disease Indication

    15.9. BENELUX Prostate Health Market Analysis

        15.9.1. Value Proportion Analysis by Market Taxonomy

        15.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.9.2.1. By Disease Indication

    15.10. UK Prostate Health Market Analysis

        15.10.1. Value Proportion Analysis by Market Taxonomy

        15.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.10.2.1. By Disease Indication

    15.11. Nordic Countries Prostate Health Market Analysis

        15.11.1. Value Proportion Analysis by Market Taxonomy

        15.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.11.2.1. By Disease Indication

    15.12. China Prostate Health Market Analysis

        15.12.1. Value Proportion Analysis by Market Taxonomy

        15.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.12.2.1. By Disease Indication

    15.13. Japan Prostate Health Market Analysis

        15.13.1. Value Proportion Analysis by Market Taxonomy

        15.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.13.2.1. By Disease Indication

    15.14. South Korea Prostate Health Market Analysis

        15.14.1. Value Proportion Analysis by Market Taxonomy

        15.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.14.2.1. By Disease Indication

    15.15. GCC Countries Prostate Health Market Analysis

        15.15.1. Value Proportion Analysis by Market Taxonomy

        15.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.15.2.1. By Disease Indication

    15.16. South Africa Prostate Health Market Analysis

        15.16.1. Value Proportion Analysis by Market Taxonomy

        15.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.16.2.1. By Disease Indication

    15.17. Turkey Prostate Health Market Analysis

        15.17.1. Value Proportion Analysis by Market Taxonomy

        15.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032

            15.17.2.1. By Disease Indication

        15.17.3. Competition Landscape and Player Concentration in the Country

16. Market Structure Analysis

    16.1. Market Analysis by Tier of Companies 

    16.2. Market Concentration

    16.3. Market Share Analysis of Top Players

    16.4. Market Presence Analysis

        16.4.1. By Regional footprint of Players

        16.4.2. Product footprint by Players

17. Competition Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Competition Deep Dive 

        17.3.1. GLAXOSMITHKLINE

            17.3.1.1. Overview

            17.3.1.2. Product Portfolio

            17.3.1.3. Sales Footprint

            17.3.1.4. Strategy Overview

        17.3.2. ASTELLAS PHARMA

            17.3.2.1. Overview

            17.3.2.2. Product Portfolio

            17.3.2.3. Sales Footprint

            17.3.2.4. Strategy Overview

        17.3.3. ALLERGAN

            17.3.3.1. Overview

            17.3.3.2. Product Portfolio

            17.3.3.3. Sales Footprint

            17.3.3.4. Strategy Overview

        17.3.4. MERCK

            17.3.4.1. Overview

            17.3.4.2. Product Portfolio

            17.3.4.3. Sales Footprint

            17.3.4.4. Strategy Overview

        17.3.5. ELI LILLY AND COMPANY

            17.3.5.1. Overview

            17.3.5.2. Product Portfolio

            17.3.5.3. Sales Footprint

            17.3.5.4. Strategy Overview

        17.3.6. ABBOTT LABORATORIES

            17.3.6.1. Overview

            17.3.6.2. Product Portfolio

            17.3.6.3. Sales Footprint

            17.3.6.4. Strategy Overview

        17.3.7. JOHNSON & JOHNSON SERVICES, INC.

            17.3.7.1. Overview

            17.3.7.2. Product Portfolio

            17.3.7.3. Sales Footprint

            17.3.7.4. Strategy Overview

        17.3.8. ABBVIE

            17.3.8.1. Overview

            17.3.8.2. Product Portfolio

            17.3.8.3. Sales Footprint

            17.3.8.4. Strategy Overview

        17.3.9. SANOFI

            17.3.9.1. Overview

            17.3.9.2. Product Portfolio

            17.3.9.3. Sales Footprint

            17.3.9.4. Strategy Overview

        17.3.10. PFIZER, INC.

            17.3.10.1. Overview

            17.3.10.2. Product Portfolio

            17.3.10.3. Sales Footprint

            17.3.10.4. Strategy Overview

18. Assumptions and Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 2: Global Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 3: Global Prostate Health Market, By Region, 2015 – 2021

Table 4: Global Prostate Health Market, By Region, 2022 – 2032

Table 5: North America Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 6: North America Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 7: North America Prostate Health Market, By Country, 2015 – 2021

Table 8: North America Prostate Health Market, By Country, 2022 – 2032

Table 9: Latin America Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 10: Latin America Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 11: Latin America Prostate Health Market, By Country, 2015 – 2021

Table 12: Latin America Prostate Health Market, By Country, 2022 – 2032

Table 13: Europe Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 14: Europe Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 15: Europe Prostate Health Market, By Country, 2015 – 2021

Table 16: Europe Prostate Health Market, By Country, 2022 – 2032

Table 17: Asia Pacific Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 18: Asia Pacific Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 19: Asia Pacific Prostate Health Market, By Country, 2015 – 2021

Table 20: Asia Pacific Prostate Health Market, By Country, 2022 – 2032

Table 21: MEA Prostate Health Market Value (US$ Mn), By Disease Indication, 2015 – 2021

Table 22: MEA Prostate Health Market Value (US$ Mn), By Disease Indication, 2022 – 2032

Table 23: MEA Prostate Health Market, By Country, 2015 – 2021

Table 24: MEA Prostate Health Market, By Country, 2022 – 2032

Table 25: Global Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 26: Global Prostate Health Market Incremental $ Opportunity, By Region, 2022 – 2032

Table 27: North America Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 28: North America Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 29: Latin America Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 30: Latin America Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 31: Europe Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 32: Europe Prostate Health Market Incremental $ Opportunity, By Country, 2022 - 2032

Table 33: Asia Pacific Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 34: Asia Pacific Prostate Health Market Incremental $ Opportunity, By Country, 2022 – 2032

Table 35: MEA Prostate Health Market Incremental $ Opportunity, By Disease Indication, 2015 - 2021

Table 36: MEA Prostate Health Market Incremental $ Opportunity, By Country, 2022 - 2032

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 1: Global Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 2: Global Prostate Health Market Absolute $ Historical Gain (2015 - 2021) and Opportunity (2022 – 2032), US$ Mn

Figure 3: Global Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 4: Global Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 5: Global Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 6: Global Prostate Health Market Share, By Region, 2022 & 2032

Figure 7: Global Prostate Health Market Y-o-Y Growth Projections, By Region – 2022-2032

Figure 8: Global Prostate Health Market Attractiveness Index, By Region – 2022-2032

Figure 9: North America Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 10: North America Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 11: North America Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 12: North America Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 13: North America Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 14: North America Prostate Health Market Share, By Country, 2022 & 2032

Figure 15: North America Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 16: North America Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 17: Latin America Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 18: Latin America Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 19: Latin America Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 20: Latin America Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 21: Latin America Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 22: Latin America Prostate Health Market Share, By Country, 2022 & 2032

Figure 23: Latin America Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 24: Latin America Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 25: Europe Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 26: Europe Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 27: Europe Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 28: Europe Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 29: Europe Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 30: Europe Prostate Health Market Share, By Country, 2022 & 2032

Figure 31: Europe Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 32: Europe Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 33: MEA Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 34: MEA Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 35: MEA Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 36: MEA Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 37: MEA Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 38: MEA Prostate Health Market Share, By Country, 2022 & 2032

Figure 39: MEA Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 40: MEA Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 41: Asia Pacific Prostate Health Market Value (US$ Mn) and Year-on-Year Growth, 2015-2032

Figure 42: Asia Pacific Prostate Health Market Absolute $ Opportunity Historical (2015 - 2021) and Forecast Period (2022 – 2032), US$ Mn

Figure 43: Asia Pacific Prostate Health Market Share, By Disease Indication, 2022 & 2032

Figure 44: Asia Pacific Prostate Health Market Y-o-Y Growth Projections, By Disease Indication – 2022-2032

Figure 45: Asia Pacific Prostate Health Market Attractiveness Index, By Disease Indication – 2022-2032

Figure 46: Asia Pacific Prostate Health Market Share, By Country, 2022 & 2032

Figure 47: Asia Pacific Prostate Health Market Y-o-Y Growth Projections, By Country – 2022-2032

Figure 48: Asia Pacific Prostate Health Market Attractiveness Index, By Country – 2022-2032

Figure 49: US Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 50: US Prostate Health Market Share, By Disease Indication, 2021

Figure 51: Canada Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 52: Canada Prostate Health Market Share, By Disease Indication, 2021

Figure 53: Brazil Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 54: Brazil Prostate Health Market Share, By Disease Indication, 2021

Figure 55: Mexico Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 56: Mexico Prostate Health Market Share, By Disease Indication, 2021

Figure 57: Germany Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 58: Germany Prostate Health Market Share, By Disease Indication, 2021

Figure 59: U.K. Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 60: U.K. Prostate Health Market Share, By Disease Indication, 2021

Figure 61: France Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 62: France Prostate Health Market Share, By Disease Indication, 2021

Figure 63: Italy Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 64: Italy Prostate Health Market Share, By Disease Indication, 2021

Figure 65: BENELUX Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 66: BENELUX Prostate Health Market Share, By Disease Indication, 2021

Figure 67: Nordic Countries Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 68: Nordic Countries Prostate Health Market Share, By Disease Indication, 2021

Figure 69: China Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 70: China Prostate Health Market Share, By Disease Indication, 2021

Figure 71: Japan Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 72: Japan Prostate Health Market Share, By Disease Indication, 2021

Figure 73: South Korea Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 74: South Korea Prostate Health Market Share, By Disease Indication, 2021

Figure 75: GCC Countries Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 76: GCC Countries Prostate Health Market Share, By Disease Indication, 2021

Figure 77: South Africa Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 78: South Africa Prostate Health Market Share, By Disease Indication, 2021

Figure 79: Turkey Prostate Health Market Value (US$ Mn) and Forecast, 2022 - 2032

Figure 80: Turkey Prostate Health Market Share, By Disease Indication, 2021

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports
Google translate

Prostate Health Market